Switzer TV

 

Welcome back for another year of stock picks, top LICs and trading tips with Switzer Investing TV. Good to have you aboard.

On this kick-off ep for the new year, we're looking at roughed-up companies on the market that might be worth a second look. Quality stocks are being sold hard, resources are back in favour, and investors are asking the same uncomfortable question, is this a buying opportunity or a value trap?

In this first show of the year, Peter Switzer sits down with Adam Dawes from Shaw and Partners, Mike Gable from Fairmont Equities, and Paul Rickard from the Switzer Report to cut through the noise.

They run the ruler over some of the market’s most talked-about names, including CSL, NextDC, Xero, WiseTech, Pro Medicus, lithium plays, uranium stocks, and gold. Fundamentals meet charts, sentiment clashes with valuation, and the panel doesn’t always agree. You’ll hear why great businesses can fall a long way without anything being “wrong”, what the charts are really saying about beaten-up tech, why resources have momentum again, and whether gold is still a defensive play with upside in 2026.

Switzer Investing TV (19/12/25): Are these smashed stocks worth your time?

On this kick-off ep for the new year, we're looking at roughed-up companies on the market that might be worth a second look. Quality stocks are being sold hard, resources are back in favour, and investors are asking the same uncomfortable question, is this a buying opportunity or a value trap?

More videos

Peter Cook from Novatti Group (ASX:NOV)

Peter Switzer sits down with the CEO of Novatti (NOV), Peter Cook.

Series:
Another new treatment for Glioblastoma

Dr Ross Walker talks about another new trial into treating Glioblastoma, one of the most aggressive brain cancers.

Series:
Will HospoKeeper replace JobKeeper?

Peter Switzer and Paul Rickard look at the potential replacements to JobKeeper, why Wall Street likes Joe Biden and what JB Hi-Fi's strong sales numbers mean for the economy.

Series:
Dr Chris Hart from Oventus Medical (ASX:OVN)

Peter Switzer speaks to the founder and CEO of Oventus (OVN), Dr Chris Hart.

Series:
BUY or SELL these hot stocks: Tyro, Z1P, A2M, ELO, EML, TWE, NXT and MP1

On this week's show, Peter Switzer is joined by Fairmont Equities' Michael Gable, Burman Invest's Julia Lee, Switzer's Paul Rickard and Avecho's Dr Paul Gavin.

Series:
Brian Ward from Aroa Biosurgery (ASX:ARX)

Peter Switzer is joined by Brian Ward, the founder and CEO of soft tissue regeneration company Aroa (ARX).

Series:
Two new treatments for Glioblastoma

Dr Ross Walker explains two studies that are finding new treatments for Glioblastoma, one of the most devastating kinds of brain tumour.

Series:
Peter Switzer & Paul Rickard look at the stocks they like for 2021

Peter and Paul take a look back on 2020 and look ahead to the stocks that will do well in 2021, plus highlights from an interview with technology entrepreneur Bevan Slattery.

Series:
Julia Lee & Jun Bei Liu gives you the stocks they really love!

Get ready for investing in 2021 with Peter Switzer, Julia Lee from Burman Invest and Jun Bei Liu from Tribeca Investment Partners, plus an interview with JB Hi-Fi CEO Richard Murray.

Series:
CEOs of Webjet and ELMO talk up their stocks

Peter Switzer shines the spotlight on Webjet and ELMO Software, plus Adam Dawes from Shawn and Partners takes a look at some stocks.

Series:
15 stocks you have to consider for 2021! Is Mesoblast one of them?

Burman Invest's Julia Lee and Switzer's Paul Rickard join Peter Switzer.

Series:
How to combat the overprescription of medication

Dr Ross Walker looks at why overprescription is happening and why you should talk to your doctor about the medications you are on.

Series: ,
1 36 37 38 39 40 51

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram